Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 26 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 8415384

    Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade

    The Board of Regents of the University of Texas System · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  2. US 8394377

    Methods for treating cancer using combination therapy

    The Regents of the University of Colorado · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  3. US 8394411

    Papillomavirus pseudoviruses for detection and therapy of tumors

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  4. US 8383099

    Adoptive cell therapy with young T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  5. US 8372826

    Estriol therapy for multiple sclerosis and other autoimmune diseases

    The Regents of the University of California · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

  6. US 8338173

    Preparation of antigen-presenting human γδ T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  7. US 8337830

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  8. US 8323906

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  9. US 2012263625

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

    AICHER DANIEL [DE] · Granted Oct 18, 2012 · Expires Oct 13, 2032

    granted

  10. US 8287857

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  11. US 8258116

    Combination therapy for the treatment of HCV infection

    Vertex Pharmaceuticals Incorporated · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  12. US 8257918

    Intelligent nanomedicine integrating diagnosis and therapy

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  13. US 8252267

    DKKL-1 splice product modulators for cancer diagnosis and therapy

    Sagres Discovery, Inc. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  14. US 8247399

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  15. US 8202242

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  16. US 8173615

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 8, 2012 · Expires May 3, 2032

    granted

  17. US 8153136

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  18. US 8153426

    Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  19. US 8153620

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  20. US 8148352

    Antimicrobial therapy for bacterial infections

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  21. US 8147805

    Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications

    The Board of Regents of the University of Texas System · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  22. US 8143232

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted

  23. US 8062643

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  24. US 8057807

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.